LabGenomics Co., Ltd. 084650.KQ Stock
2575 KRW
{{ price }}
-2.646503%
{{change_pct}}%
COUNTRY
South Korea
Exchange
KOSDAQ
Market Cap
191.17B KRW
LOW - HIGH [24H]
2570
-
2670 KRW
VOLUME [24H]
676.93K KRW
{{ volume }}
P/E Ratio
0
Earnings per share
0 KRW
LabGenomics Co., Ltd. Price Chart
LabGenomics Co., Ltd. 084650.KQ Financial and Trading Overview
LabGenomics Co., Ltd. stock price | 2575 KRW |
Previous Close | 6070 KRW |
Open | 6080 KRW |
Bid | 6100 KRW x N/A |
Ask | 6110 KRW x N/A |
Day's Range | 6080 - 6220 KRW |
52 Week Range | 5070 - 9690 KRW |
Volume | 163.54K KRW |
Avg. Volume | 1.02M KRW |
Market Cap | 55.37B KRW |
Beta (5Y Monthly) | -0.72589 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
084650.KQ Valuation Measures
Enterprise Value | 139.92B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.29607236 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 0.748 |
Enterprise Value/EBITDA | 1.358 |
Trading Information
LabGenomics Co., Ltd. Stock Price History
Beta (5Y Monthly) | -0.72589 |
52-Week Change | 5.74% |
S&P500 52-Week Change | 20.43% |
52 Week High | 9690 KRW |
52 Week Low | 5070 KRW |
50-Day Moving Average | 6084 KRW |
200-Day Moving Average | 6383.65 KRW |
084650.KQ Share Statistics
Avg. Volume (3 month) | 1.02M KRW |
Avg. Daily Volume (10-Days) | 263.18K KRW |
Shares Outstanding | 9.08M |
Float | 27.17M |
Short Ratio | N/A |
% Held by Insiders | 11.64% |
% Held by Institutions | 2.39% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor | 3:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | 39.65% |
Operating Margin (ttm) | 53.16% |
Gross Margin | 67.41% |
EBITDA Margin | 55.08% |
Management Effectiveness
Return on Assets (ttm) | 28.62% |
Return on Equity (ttm) | 42.42% |
Income Statement
Revenue (ttm) | 187.01B KRW |
Revenue Per Share (ttm) | 5550.65 KRW |
Quarterly Revenue Growth (yoy) | -54.10% |
Gross Profit (ttm) | 124.89B KRW |
EBITDA | 103.01B KRW |
Net Income Avi to Common (ttm) | 74.15B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | -67.90% |
Balance Sheet
Total Cash (mrq) | 105.71B KRW |
Total Cash Per Share (mrq) | 3110 KRW |
Total Debt (mrq) | 21.25B KRW |
Total Debt/Equity (mrq) | 9.98 KRW |
Current Ratio (mrq) | 7.608 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 67.15B KRW |
Levered Free Cash Flow (ttm) | 19.79B KRW |
Profile of LabGenomics Co., Ltd.
Country | South Korea |
State | N/A |
City | Seongnam-si |
Address | Korea Bio Park B-dong |
ZIP | N/A |
Phone | 82 3 1628 0700 |
Website | https://www.labgenomics.co.kr |
Industry | |
Sector(s) | |
Full Time Employees | 228 |
LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea.
Q&A For LabGenomics Co., Ltd. Stock
What is a current 084650.KQ stock price?
LabGenomics Co., Ltd. 084650.KQ stock price today per share is 2575 KRW.
How to purchase LabGenomics Co., Ltd. stock?
You can buy 084650.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for LabGenomics Co., Ltd.?
The stock symbol or ticker of LabGenomics Co., Ltd. is 084650.KQ.
How many shares does LabGenomics Co., Ltd. have in circulation?
The max supply of LabGenomics Co., Ltd. shares is 74.24M.
What is LabGenomics Co., Ltd. Price to Earnings Ratio (PE Ratio)?
LabGenomics Co., Ltd. PE Ratio is now.
What was LabGenomics Co., Ltd. earnings per share over the trailing 12 months (TTM)?
LabGenomics Co., Ltd. EPS is 0 KRW over the trailing 12 months.